Richard Siderits Selected Research

COVID-19

10/2022

Antibody Seroprevalence, Infection and Surveillance for SARS-CoV-2 in Residents and Staff of New Jersey Long-Term Care Facilities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Siderits Research Topics

Disease

1	Infections 10/2022
1	COVID-19 10/2022
1	Hemorrhage 01/2012
1	Abdominal Pain (Pain, Abdominal) 01/2012
1	Nausea 01/2012
1	Hemangiosarcoma (Angiosarcoma) 01/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2006
1	Ascites 05/2006
1	Neoplasms (Cancer) 01/2005
1	Breast Neoplasms (Breast Cancer) 01/2005

Drug/Important Bio-Agent (IBA)

1	Nucleocapsid ProteinsIBA 10/2022
1	AntigensIBA 10/2022
1	Polyvinyl Chloride (PVC)IBA 01/2012
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2006
1	Charcoal (Charbon)IBA 01/2005
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2005
1	ParaffinIBA 01/2005
1	Estrogen ReceptorsIBA 01/2005
1	Dextrans (Dextran)FDA Link 01/2005

Therapy/Procedure

1	Long-Term Care 10/2022
1	Drug Therapy (Chemotherapy) 01/2012